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Moratalla Rovira14, Nerea Muniozguren Agirre15, José Luis Sánchez-RamosID
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Most women live to experience menopause and will spend 4–8 years transitioning from fer-
tile age to full menstrual stop. Biologically, reproductive ageing is a continuous process, but
by convention, it is defined categorically as pre-, peri- and postmenopause; categories that
are sometimes supported by measurements of sex hormones in blood samples. We aimed
to develop and validate a new tool, a reproductive ageing score (RAS), that could give a sim-
ple and yet precise description of the status of reproductive ageing, without hormone mea-
surements, to be used by health professionals and researchers.
Methods
Questionnaire data on age, menstrual regularity and menstrual frequency was provided by
the large multicentre population-based RHINE cohort. A continuous reproductive ageing
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to completely replicate the reproductive ageing
score was developed from these variables, using techniques of fuzzy mathematics, to gen-
erate a decimal number ranging from 0.00 (nonmenopausal) to 1.00 (postmenopausal). The
RAS was then validated with sex hormone measurements (follicle stimulating hormone and
17β-estradiol) and interview-data provided by the large population-based ECRHS cohort,
using receiver-operating characteristics (ROC).
Results
The RAS, developed from questionnaire data of the RHINE cohort, defined with high preci-
sion and accuracy the menopausal status as confirmed by interview and hormone data in
the ECRHS cohort. The area under the ROC curve was 0.91 (95% Confidence interval (CI):
0.90–0.93) to distinguish nonmenopausal women from peri- and postmenopausal women,
and 0.85 (95% CI: 0.83–0.88) to distinguish postmenopausal women from nonmenopausal
and perimenopausal women.
Conclusions
The RAS provides a useful and valid tool for describing the status of reproductive ageing
accurately, on a continuous scale from 0.00 to 1.00, based on simple questions and without
requiring blood sampling. The score allows for a more precise differentiation than the con-
ventional categorisation in pre-, peri- and postmenopause. This is useful for epidemiological
research and clinical trials.
1. Introduction
Menopause marks the cessation of menstruations and the end of the reproductive part of life
[1]. This transition, which occurs in women around 50 years of age, takes on average five years
and is a major part of reproductive ageing [2, 3]. It also implies profound hormonal changes: a
woman’s estrogen levels start to decline, and her gonadotropin levels begin to rise. The result
is that her body gradually changes into a non-reproductive state [4, 5]. Epidemiological
research traditionally uses categories to describe the reproductive status of a woman, such as
perimenopausal or postmenopausal. These categories are based on arbitrary thresholds; they
may be rather heterogeneous and lead to an aggravated interpretation of research findings. As
an example, the current consensus, the Stages of Reproductive Ageing Workshop (STRAW)
defines late perimenopause as a stage lasting one to three years, during which women experi-
ence amenorrhea for 60 days or more [6]. This evidently conglomerates a range of women of
different reproductive ages, who would then be jointly analysed in an epidemiological study.
Categorization may facilitate communication between clinicians and the public, but it does
not reflect the underlying biology and it introduces clear limitations, especially for epidemio-
logical research on women undergoing the menopausal transition [7]. The frequent use of cat-
egories can however be understood, as there is to date no single biomarker sufficiently
describing menopause [6, 8].
We aim to mathematically describe the status of reproductive ageing and create an easy to
replicate reproductive ageing score based on the age of a woman and the number and regular-
ity of menstruations she experiences.
PLOS ONE A reproductive ageing score
PLOS ONE | https://doi.org/10.1371/journal.pone.0235478 June 30, 2020 2 / 16
score. Data used for the validation of the score,
such as hormone measurements and other
covariates are sensitive patient information and due
to Norwegian ethical and legal restrictions only
available upon request to qualified researchers. The
institutional body responsible for restricting the
data is the European Community Respiratory
Health Survey consortium. Requests for data
access can be directed to Haukeland University
Hospital, 5021 Bergen, Norway, Att. Med. Director
Alf H. Andreassen; e-mail: postmottak@helse-
bergen; phone: +47 55 97 50 00. Org. nr: 983 974
724.
Funding: Kai Triebner has received a postdoctoral
fellowship from the University of Bergen. The
present analyses are part of a project funded by the
Norwegian Research Council (Project No. 228174)
as well as part of the Ageing Lungs in European
Cohorts (ALEC) Study (www.alecstudy.org), which
has received funding from the European Union’s
Horizon 2020 research and innovation program
(Grant No. 633212). The European Commission
supported the European Community Respiratory
Health Survey, as part of the “Quality of Life”
program. Bodies funding the local studies are listed
in the supporting information. The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
2. Materials and methods
We used data from two population-based cohorts, the Respiratory Health in Northern Europe
(RHINE) study and the European Community Respiratory Health Survey (ECRHS). Ethical
approval was obtained for each centre of the RHINE study and the ECRHS from the appropri-
ate institutional or regional ethics committee and each participant provided informed written
consent prior to inclusion in the studies.
2.1 RHINE
Bergen: Regional Committee for Medical and Health Research Ethics in Western Norway
(2010/759); Reykjavik: National Bioethics Committee of Iceland (VSN 11–121); Uppsala,
Umeå, Göteborg: Ethics Committee of Uppsala University (2010/068); Aarhus: not required
for questionnaire-only studies; Tartu: Research Ethics Committee of the University of Tartu
(209/T-17);
2.2 ECRHS
Aarhus: Scientific ethical committee for Region Midtlylland; Albacete: Comité Ético de Inves-
tigación Clı́nica del Hospital Universitario de Albacete; Galdakao: Comité Ético de Investiga-
ción Clı́nica del Hospital de Galdakao-Usansolo; Huelva: Comisión de Ética de Investigación
Sanitarias del Hospital Juan Ramón Jiménez de Huelva; Bergen: Regional Committee for Med-
ical and Health Research Ethics in Western Norway (2010/759); Bordeaux, Grenoble, Mont-
pellier, Paris: Comite De Protection Des Personnes (2011-A00013-38); Erfurt, Hamburg:
Ethikkommission der Bayerischen Landesärztekammer (Reg Nr. 10015); Uppsala, Umeå,
Göteborg: Ethics Committee of Uppsala University (2010/068); Reykjavik: National Bioethics
Committee of Iceland (VSN 11–121); Tartu: Research Ethics Committee of the University of
Tartu (209/T-17);
2.3 Development and validation population
The reproductive ageing score (RAS) was developed using data of subjects participating in the
questionnaire-based RHINE study and it was validated in the population of the ECRHS where
objective sex hormone measurements were available.
The RHINE study is a longitudinal, international, multi-centre study (www.rhine.nu),
which includes seven Northern European centres (Bergen in Norway; Reykjavik in Iceland;
Umeå, Uppsala and Göteborg in Sweden; Aarhus in Denmark and Tartu in Estonia). For the
current paper, we used data from the most recent wave, carried out between 2010 and 2012
with a response rate of 63% [9]. We used data from 3107 women with a mean age of 52 years
(range: 38–66 years) to develop the RAS.
The ECRHS also is a longitudinal, international, multicentre study (www.ecrhs.org) [10,
11]. The validation population includes women from 16 centres in nine countries who partici-
pated during 2010 to 2012 (Aarhus in Denmark; Albacete, Galdakao and Huelva in Spain; Ber-
gen in Norway; Bordeaux, Grenoble, Montpellier and Paris in France; Erfurt and Hamburg in
Germany; Göteborg, Umeå and Uppsala in Sweden; Reykjavik in Iceland and Tartu in Esto-
nia). The available serum samples were analysed for concentrations of follicle stimulating hor-
mone (FSH) and 17β-estradiol. The database contained 1056 women with a mean age of 55
years (range: 40–67 years). For the seven Northern European centres in ECRHS, participants
were also a subsample of the RHINE study. Women who participated in both surveys were
included into the validation population but not the development population. We further
excluded women from both populations who currently used exogenous sex hormones like
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contraceptives or hormone replacement therapy (including intermittent progestin therapy),
women being pregnant or breastfeeding at the time of the surveys and women reporting irreg-
ular menstruation unrelated to menopause (Fig 1) [6, 12, 13].
Fig 1. Flow chart of the development population (left) and validation population (right) with inclusion criteria. RHINE:
Respiratory Health in Northern Europe study, ECRHS: European Community Respiratory Health Survey.
https://doi.org/10.1371/journal.pone.0235478.g001
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2.4 Score development
To develop the score we used techniques of fuzzy set theory, a mathematical concept to depict
the biology of physiological processes [14, 15]. It was created in 1964 and successfully imple-
mented in biology, artificial intelligence, and linguistics [14, 16, 17]. Unlike conventional
mathematics, which does not allow vague expressions and demands that an object either is a
member of a set or not, fuzzy sets are defined by a function (μ) assigning a value between 0.00
and 1.00 to an observation, representing the degree of belonging to a fuzzy set. The value 1.00
means that an object completely belongs to the set and the value 0.00 means the object does
not at all belong to the set.
We first defined a function μA based on the number of periods per year and the menstrual
regularity. The function requires the proportion P(period) of regularly menstruating women
for every single number of reported periods as answers to the question: “How may periods did
you have in the last twelve months?”. A cross-tabulation (Table 1) of the menstrual regularity
(answers to the question: “Do you have regular periods?”, possible answers: “Yes”, “No, they
have been irregular for a few months”, “No, my periods have stopped”) and the number of
periods, illustrates the entirety of all values for P(period) calculated with Eq 1.
PðperiodÞ ¼
x ðperiodÞ
½xðperiodÞ þ yðperiodÞ þ zðperiodÞ�
Equation 1. Proportion of women who have regular menstruation for each number of
reported menstruations in the last year (with period = number of periods per year,
x = number of women answering “Yes” to the question: “Do you have regular periods?”,
Table 1. Pattern and number of menstruations in the last year among 3107 women (RHINE).
"Do you have regular periods?"






















0 0 0 1742 1742 0.000
1 1 1 34 36 0.028
2 2 10 26 38 0.053
3 3 9 11 23 0.130
4 5 18 10 33 0.152
5 3 15 7 25 0.120
6 6 14 5 25 0.240
7 6 24 5 35 0.171
8 13 17 6 36 0.361
9 13 23 3 39 0.333
10 24 28 1 53 0.453
11 66 22 1 89 0.742
12 779 31 1 811 0.961
13 61 6 0 67 0.910
14 23 8 0 31 0.742
15 12 12 0 24 0.500
Total 1017 238 1852 3107
a“No, they have been irregular for a few months”,
b“No, my periods have stopped”,
cProportion of women with regular menstruation (calculated with Eq 1)
https://doi.org/10.1371/journal.pone.0235478.t001
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y = number of women answering “No, they have been irregular for a few months” and
z = number of women answering “No, my periods have stopped”, e.g. x(11) = number of
women reporting regular menstruation among those who report 11 menstruations in the last
12 months).
For women reporting zero menstruations per year this proportion is expected to be zero, as
those women are most likely menopausal, while for women reporting twelve menstruations
per year it is expected to approach one, as those women are most likely nonmenopausal. For
women who report more than twelve menstruations per year it is expected to decline again, as
shortening as well as lengthening cycles are an indicator of the beginning menopausal transi-
tion [18]. Plotting the complementary proportion 1-P(period) versus the corresponding num-
ber of periods per year, depicts a discrete function, from which the continuous function μA can
be approximated using the least squares function approximation.
A second function μB was defined based on age. The construction of μB requires the propor-
tion P(age) of women whose menstruations have already stopped for every single reported age.
A cross-tabulation of the menstrual status with the reported ages illustrates the entirety of all
values for P(age) calculated with Eq 2 (Table 2).
PðageÞ ¼
z ðageÞ
½xðageÞ þ yðageÞ þ zðageÞ�
Equation 2. Proportion of women whose menstruations have already stopped, for each
reported year of age (with age = age in years, x = number of women answering “Yes” to the
question: “Do you have regular periods?”, y = number of women answering “No, they have
been irregular for a few months”, z = number of women answering “No, my periods have
stopped”, e.g. x(40) = number of women reporting regular menstruations among those who
are 40 years old).
This proportion increases with age and for younger women this proportion is expected to
be low. Plotting the proportion P(age) versus the corresponding age depicts a discrete func-
tion, from which the continuous function μB can be approximated using the least squares func-
tion approximation.
Additionally, two optional modifiers were introduced to μB: smoking and unilateral oopho-
rectomy. According to recent literature, current smoking is associated with two years [19] and
unilateral oophorectomy with one year [20] younger age at menopause. Therefore, two years
were added to the age of current smokers and one year was added to the age of women report-
ing unilateral oophorectomy, defining the new variable mage (modified age) (Eq 3).
mage ¼
age for non   smokers with two ovaries
ageþ 1 for non   smokers with one ovary
ageþ 2 for smokers with two ovaries








Equation 3. Age modification by smoking and oophorectomy.
Subsequently, the value for the function μB is defined from P(mage).
The calculated probability of being not regularly menstruating or without menses, accord-
ing to the number of periods within the last twelve months (μA), does not depend on the wom-
an’s age, thus allowing to calculate the probability for each year of being either amenorrheic or
not regularly menstruating. Thus, the RAS can be calculated as the union of μA and μB by
PLOS ONE A reproductive ageing score
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adding the two sets (μA + μB) and subtracting the overlap, i.e. the repeated elements of the
intersection (μAμB):
RAS ¼ mA þ mB   mAmB
Equation 4. The reproductive ageing score as an aggregation function of μA and μB.
The union of μA and μB can be imagined within a three-dimensional Cartesian coordinate
system, where μA is projected on the planes parallel to the one spanned by the x- and z-axis for
each increment of μB and is projected on the planes parallel to the one spanned by the y- and
z-axis for each increment of μB. Subsequently the function, representing the union of μA and
μB is formed by the maximum value of either function (μA or μB) for any given coordinates of
Table 2. Presence of menstruations by age among 3107 women (RHINE).
"Do you have regular periods?"






38 5 0 0 5 0.000
39 33 2 2 37 0.054
40 86 6 5 97 0.052
41 79 10 2 91 0.022
42 87 7 5 99 0.051
43 99 8 9 116 0.078
44 98 14 14 126 0.111
45 78 19 19 116 0.164
46 86 13 23 122 0.189
47 83 17 24 124 0.194
48 58 19 28 105 0.267
49 47 26 45 118 0.381
50 32 27 52 111 0.468
51 32 20 77 129 0.597
52 27 23 93 143 0.650
53 13 14 101 128 0.789
54 8 8 122 138 0.884
55 9 0 135 144 0.938
56 3 3 116 122 0.951
57 2 1 131 134 0.978
58 6 0 129 135 0.956
59 7 0 120 127 0.945
60 12 0 115 127 0.906
61 8 1 131 140 0.936
62 9 0 158 167 0.946
63 6 0 96 102 0.941
64 4 0 86 90 0.956
65 0 0 13 13 1.000
66 0 0 1 1 1.000
Total 1017 238 1852 3107
1 “No, they have been irregular for a few months”
2 “No, my periods have stopped”
3 Proportion of women without menstruation (calculated with Eq 2)
https://doi.org/10.1371/journal.pone.0235478.t002
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the plane spanned by the x- and y-axis. Thus, Eq 4 can be applied for any woman, knowing the
following variables: age, number of periods in the last year, age, oophorectomy (“Never”, “One
ovary”, “Both ovaries”) and the smoking status (“Yes” / “No”).
2.5 Validation of the developed score
We used receiver operating characteristics (ROC) to validate the calculated score against estab-
lished hormone cut-offs in our validation population (ECRHS) [21] (nonmenopausal: FSH
�20IU/L and 17β-estradiol�147pmol/L, postmenopausal: FSH�80IU/L and 17β-estradiol
�73pmol/L [22]. ROC curves show the true positive rate (sensitivity) against the false positive
rate (specificity) and compare to random guessing. An area under the curve (AUC) of one
would indicate perfect performance. We validated two concepts. First, we tested how well the
score separated nonmenopausal women from the remaining (perimenopausal and postmeno-
pausal) women and second, how well the score separated postmenopausal women from the
remaining (nonmenopausal and perimenopausal) women. As perimenopausal women score
by definition intermediate values, they were evaluated by comparing intermediate cut-offs of
the score to hormone levels and menstrual pattern. For the sake of completeness, this was also
done for nonmenopausal and postmenopausal women. Additionally, in order to visualize the
performance of the RAS, we include a boxplot of the RAS against three commonly used cate-
gories defined by hormonal measurements in the supporting information (S1 Fig).
The least square approximations to develop the RAS were performed using the Maxima
CAS (Computer Algebra System) software [23]. All other calculations, including the validation
of the RAS, were performed using the R statistical package [24].
3. Results
The cross-tabulated data to derive the first function μA based on P(period) is presented in
Table 1. This function can be approximated by a biquadratic exponential function with a
mean-squared error (MSE) of 0.011 (Eq 5). It shows, consistently with existing literature, that
the transition to menopause is characterized by an increased frequency of both very long and
very short cycles (Fig 2) [18].
1   mA ¼ e
  0:00047ðperiod  0:7Þ4þ0:009ðperiod  0:7Þ3   0:0307ðperiod  0:7Þ2þ0:086ðperiod  0:7Þ  2:317
Equation 5. Biquadratic exponential function μA depending of the number of periods.
The tabulated data to derive the second function μB (Eq 6) based on P(age) is presented in
Table 2.
The calculated proportion of women who indicate being menopausal by answering “No” to
the question "Do you have regular periods?" of all women of the same age (μB) can be approxi-
mated by a quadratic logistic function (Fig 3) with a MSE for this approximation of 0.002.
mB ¼
eð0:0047 age2   0:0866 age  7:646Þ
ð1þ eð0:0047 age2   0:0866 age  7:646ÞÞ
Equation 6. Quadratic logistic function approximating the function μB (with age in years).
PLOS ONE A reproductive ageing score
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Finally, the function of the RAS (Eq 7) according to the aggregation expressed in Eq 4:
RAS ¼ ð1   e  0:00047ðperiod  0:7Þ4þ0:009ðperiod  0:7Þ3   0:0307ðperiod  0:7Þ2þ0:086ðperiod  0:7Þ  2:317Þ þ
eð0:0047 age2   0:0866 age   7:646Þ
ð1þ eð0:0047 age2  0:0866 age   7:646ÞÞ
  ð1 
e  0:00047ðperiod  0:7Þ4þ0:009ðperiod  0:7Þ3  0:0307ðperiod  0:7Þ2þ0:086ðperiod  0:7Þ  2:317Þ �
eð0:0047 age2  0:0866 age   7:646Þ
ð1þ eð0:0047 age2   0:0866 age   7:646ÞÞ
Fig 2. Approximated function for menstrual regularity. Data points: Inverse proportion of women with regular menstruation for every
response to the number of periods during the last year, observed in the RHINE dataset 1-P(period); Line: biquadratic exponential function μA
with best fit to observed values 1-P(period).
https://doi.org/10.1371/journal.pone.0235478.g002
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Equation 7. Final formula to calculate the reproductive ageing score (RAS) (with period
being the number of periods per year and age as the age in years, modified according to smok-
ing status and oophorectomy).
Graphically the RAS can be represented as a three-dimensional figure (Fig 4) using the vari-
ables period along the x-axis and age along the y-axis.
Both, older age and fewer menstruations contribute to a higher RAS and indicate progres-
sion into a postmenopausal state. Smoking and oophorectomy act as modifiers of the function
μB and thus the RAS. We calculated the RAS for women within the validation population
(ECRHS) with Eq 7, which was derived from the development population (RHINE).
Fig 3. Approximated function for age. Data points: Proportion of women without menstruations according to age observed in the RHINE
dataset P(age); Line: quadratic logistic function μB with best fit to observed values P(age).
https://doi.org/10.1371/journal.pone.0235478.g003
PLOS ONE A reproductive ageing score
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The area under the ROC curve was 0.91 (95% CI: 0.90–0.93) to distinguish nonmenopausal
women from the remaining perimenopausal and postmenopausal women (Fig 5, black curve)
and 0.85 (95% CI: 0.83–0.88) to distinguish postmenopausal women from the remaining non-
menopausal and perimenopausal women (Fig 5, grey curve), as defined by concentrations of
FSH and 17β-estradiol.
Table 3 shows reproductive characteristics for quartiles of the RAS, to illustrate the repro-
ductive characteristics of women with intermediate reproductive ageing scores (0.26–0.75),
who are presumed to be in the menopausal transition.
4. Discussion
We developed a continuous reproductive ageing score based on age and number of menstrua-
tions. Calculating this score for each woman in the validation population (ECRHS) showed
that women with the lowest scores featured nonmenopausal characteristics [21, 25]. Women
who scored intermediate values showed characteristics of advancing degrees of the meno-
pausal transition and women who scored highest strongly resembled typical postmenopausal
women [21, 25]. The RAS can be interpreted as an indicator of the progress of reproductive
ageing. Women with a score of 0.00 can be considered premenopausal and women with a
score of 1.00 can be considered postmenopausal, while the intermediate values can be consid-
ered advancing degrees of reproductive ageing in terms of decreasing fertility, respectively
depletion of the ovarian reserve.
The validation with ROC curves and the practical example (supporting information) pre-
sented the RAS as a useful tool for epidemiologists. The performance of the RAS for women
who were either nonmenopausal or postmenopausal was very good, with AUC values of 0.91
and 0.85, respectively. The ROC curve validation shows that the RAS discriminates nonmeno-
pausal women slightly better than postmenopausal women. The score was able to quantify
degrees of the menopausal transition, which has so far not been possible, resulting in women
at different stages of reproductive ageing being defined as one heterogeneous group. This tool
has great potential to offer new insights into health and disease, e.g. whether women are
Fig 4. Unique function of the reproductive ageing score (RAS) (with menstruations per year on the x-axis, age on
the y-axis and the RAS, expressed as percentage on the z-axis).
https://doi.org/10.1371/journal.pone.0235478.g004
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vulnerable to a certain health condition during a narrow time window within the perimen-
opausal phase.
In addition, the mean square deviation of the calculated functions reaches values very close
to zero, implying a strong nonlinear correlation between the independent variables (number
of periods in the last year and age) and the proportions, calculated within the development
population. Concerning μA, possibly less precise data in the upper range of menstruations per
year (>12), due to the lower number of data points, is largely being adjusted for by the relation
with age (μB) after forming the final function (RAS). The RAS is based on the strong
Fig 5. Receiver operating characteristic for validation of the reproductive ageing score by combined FSH and 17β-estradiol cut-offs in the
validation population (ECRHS). Black curve: Nonmenopausal women versus perimenopausal and postmenopausal women; Grey curve:
Postmenopausal women versus perimenopausal and nonmenopausal women.
https://doi.org/10.1371/journal.pone.0235478.g005
PLOS ONE A reproductive ageing score
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association between age and the changing number of menstrual periods and its major strength
is to quantify reproductive ageing continuously and that it is based on answers to a few simple
questions. Important factors influencing reproductive ageing are unilateral oophorectomy and
current smoking behaviour, both related to a younger age at menopause, which we accounted
for as modifiers. In the case that it is desirable to evaluate smoking behaviour and/or unilateral
oophorectomy separately or in a different manner, these modifiers may be removed from the
calculation of the RAS.
Another strength is that the RAS can be easily used with all common statistical software
and spread sheets by applying the final formula (Eq 7) to a dataset. To replicate the develop-
ment of the RAS (least square approximations) in other settings we recommend using the
open-source software Maxima CAS (https://sourceforge.net/projects/maxima/files/), a special-
ized computer algebra system that yields high precision numerical results and is capable of
including and evaluating complex operations, such as Taylor series and Laplace transforms as
well as linear algebra tools like matrix operations, which have been used for the current
calculations.
The proportions of women with regular menstruation for the various reported number of
periods as well as ages correspond well to the general consensus and what has been described
in other studies [6, 8, 22]. Both the development population and the validation population are
representative for the women in the relevant age groups in Europe [9], thus the external valid-
ity is high for Caucasian populations. For other ethnicities, the functions might have to be
slightly modified as age at menopause might differ.
A limitation of the RAS is that potential factors affecting reproductive ageing such as
chronic disease, gynaecological disorders and the use of exogenous hormones, are not consid-
ered. These limitations are however also acknowledged in the STRAW +10 model [26], which,
today, is considered to be the gold standard for assessing reproductive ageing.
It must also be noted that a continuous RAS, indicating how far along a woman is on her
way from fertile age to menopause (0.00–1.00) should not be confused with menopause scores
assessing women’s health after menopause or climacteric symptoms [27, 28].
5. Conclusion
The RAS provides a new, innovative and useful tool to describe the current status of reproduc-
tive ageing accurately, on a continuous scale from 0.00 to 1.00, based on simple questions and
without a need for blood measurements. The score allows for a more precise differentiation
between women during this period than the current, conventional categorisation into pre-,
Table 3. Quartiles of the reproductive ageing score versus age, menstrual and endocrine status in the validation
population (ECRHS).
Reproductive ageing score (Quartiles) 0.00–0.25 0.26–0.50 0.51–0.75 0.76–1.00
Age, mean (SD1) [years] 43.6 (1.9) 47.5 (1.9) 50.2 (2.4) 56.7 (5.5)
Periods last 12 months, mean (SD1) 12.1 (0.3) 12.0 (0.7) 11.7 (1.4) 1.2 (3.2)
Regular menses [%] 93 97 75 2
Irregular menses [%] 7 3 25 11
Amenorrhea [%] 0 0 0 87
FSH, median (IQR2) [IU/L] 11 (7–16) 17 (9–27) 22 (11–48) 124 (83–166)
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peri- and postmenopause. It thus is useful for epidemiological research and in the design of
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